drugset / Trial / NCT04156698
Induction Chemotherapy Combined With Immunotherapy for Locally Advanced Hypopharyngeal Carcinoma
NaSingle-groupOpen-labelTreatment
Summary
This is a single-center, multidisciplinary, open-label, single-arm prospective clinical study.
Timeline
- Start
- 2020-05-21
- Primary completion
- 2023-04-16
- Completion
- 2026-01-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Camrelizumab | Monoclonal antibody | 200 mg | Intravenous |
| Subject | Capecitabine | Small molecule | 800 mg/m2 | Oral |
| Subject | Cisplatin | Other / unclassified | 25 mg/m2 | Intravenous |
| Subject | Docetaxel | Small molecule | 75 mg/m2 | Intravenous |